WO2003016480A3 - Tgf-$g(a) polypeptides, functional fragments and methods of use therefor - Google Patents
Tgf-$g(a) polypeptides, functional fragments and methods of use therefor Download PDFInfo
- Publication number
- WO2003016480A3 WO2003016480A3 PCT/US2002/026023 US0226023W WO03016480A3 WO 2003016480 A3 WO2003016480 A3 WO 2003016480A3 US 0226023 W US0226023 W US 0226023W WO 03016480 A3 WO03016480 A3 WO 03016480A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- tgf
- polypeptides
- functional fragments
- use therefor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002336355A AU2002336355A1 (en) | 2001-08-17 | 2002-08-16 | Tgf-$g(a) polypeptides, functional fragments and methods of use therefor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/932,172 | 2001-08-17 | ||
US09/932,172 US6815418B2 (en) | 1999-08-19 | 2001-08-17 | TGF-α polypeptides, functional fragments and methods of use therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003016480A2 WO2003016480A2 (en) | 2003-02-27 |
WO2003016480A3 true WO2003016480A3 (en) | 2004-11-11 |
Family
ID=25461892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/026023 WO2003016480A2 (en) | 2001-08-17 | 2002-08-16 | Tgf-$g(a) polypeptides, functional fragments and methods of use therefor |
Country Status (3)
Country | Link |
---|---|
US (1) | US6815418B2 (en) |
AU (1) | AU2002336355A1 (en) |
WO (1) | WO2003016480A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273534A (en) * | 1997-08-04 | 2000-11-15 | 加利福尼亚大学董事会 | Method for treating neurological deficits |
US20010007657A1 (en) * | 1997-08-04 | 2001-07-12 | Reid James Steven | Compositions and methods for manipulating glial progenitor cells and treating neurological deficits |
US7795202B2 (en) | 1997-08-04 | 2010-09-14 | Neurorepair, Inc. | Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a) |
US20020193301A1 (en) | 1999-08-19 | 2002-12-19 | Stem Cell Pharmaceuticals, Inc. | TGF-alpha polypeptides, functional fragments and methods of use therefor |
EP1210102B1 (en) * | 1999-08-19 | 2010-04-07 | Applied Protein Sciences, LLC | Tgf-alpha polypeptides, functional fragments and methods of use therefor |
US7838292B1 (en) | 2001-03-29 | 2010-11-23 | University Of Louisville Research Foundation, Inc. | Methods for obtaining adult human olfactory progenitor cells |
US9549895B2 (en) * | 2004-04-23 | 2017-01-24 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
US20060184251A1 (en) * | 2005-01-07 | 2006-08-17 | Zongtao Zhang | Coated medical devices and methods of making and using |
JP5058822B2 (en) | 2005-01-25 | 2012-10-24 | ファイブ プライム セラピューティクス, インコーポレイテッド | Compositions and methods for treating cardiac conditions |
CA2609728A1 (en) * | 2005-05-27 | 2006-11-30 | Five Prime Therapeutics, Inc. | Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
CN101588826A (en) * | 2006-08-02 | 2009-11-25 | 英孚拉玛特公司 | Lumen-supporting devices and methods of making and using |
WO2008016712A2 (en) * | 2006-08-02 | 2008-02-07 | Inframat Corporation | Medical devices and methods of making and using |
US20100034808A1 (en) * | 2006-11-21 | 2010-02-11 | Toru Nakazawa | Compositions and methods for preserving cells of the eye |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885956A (en) * | 1992-12-14 | 1999-03-23 | Research Triangle Pharmaceuticals | Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3382562D1 (en) | 1982-09-24 | 1992-06-25 | Us Health | ANIMAL TISSUE RECOVERY. |
US4863899A (en) | 1983-05-09 | 1989-09-05 | Todaro George J | Biologically active polypeptides |
EP0154434B1 (en) | 1984-02-17 | 1993-01-27 | Genentech, Inc. | Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods |
US4749683A (en) | 1985-01-25 | 1988-06-07 | President And Fellows Of Harvard College | Inhibition of gastric acid secretion with alpha-transforming growth factor |
CA1275922C (en) | 1985-11-28 | 1990-11-06 | Harunobu Amagase | Treatment of cancer |
US4874746A (en) | 1987-12-22 | 1989-10-17 | Institute Of Molecular Biology, Inc. | Wound headling composition of TGF-alpha and PDGF |
US5658894A (en) | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
US5102870A (en) | 1989-04-14 | 1992-04-07 | Schering Ag | Treatment and prevention of oral mucositis with growth factors |
US5886141A (en) | 1990-10-26 | 1999-03-23 | Takeda Chemical Industries, Ltd. | Smooth muscle mitogen peptides and DNA coding therefor |
US5229493A (en) | 1990-10-26 | 1993-07-20 | Children's Medical Center Corporation | Smooth muscle mitogen |
JPH04352800A (en) | 1990-10-26 | 1992-12-07 | Childrens Medical Center Corp:The | Smooth muscle mitogen |
US5604202A (en) | 1990-11-13 | 1997-02-18 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Use of NGF growth factors to treat drug-induced neuropathy |
US5981165A (en) | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
US5980885A (en) | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | Growth factor-induced proliferation of neural precursor cells in vivo |
US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
US6071889A (en) | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
US6558952B1 (en) | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
KR960700067A (en) | 1993-01-29 | 1996-01-19 | 사우엘 웨이스 | GENETIC MODIFICATION OF NEURAL STEM CELLS |
DE69626034T2 (en) | 1995-11-09 | 2003-08-14 | Takeda Chemical Industries Ltd | COMPOSITION FOR IMPROVING PANCREAS FUNCTION |
US5814308A (en) | 1996-03-26 | 1998-09-29 | Zhang; Ke | Methods for the treatment of gastrointestinal tract disorders |
CA2266659A1 (en) | 1996-11-15 | 1998-05-28 | Paule Poulin | Pretreatment with growth factors to protect against cns damage |
US6114307A (en) | 1996-12-16 | 2000-09-05 | Zymogenetics, Inc. | Methods for stimulating pancreatic islet cell regeneration |
CN1273534A (en) | 1997-08-04 | 2000-11-15 | 加利福尼亚大学董事会 | Method for treating neurological deficits |
EP1175487A2 (en) | 1999-02-10 | 2002-01-30 | Curis, Inc. | Pancreatic progenitor cells, methods and uses related thereto |
-
2001
- 2001-08-17 US US09/932,172 patent/US6815418B2/en not_active Expired - Fee Related
-
2002
- 2002-08-16 AU AU2002336355A patent/AU2002336355A1/en not_active Abandoned
- 2002-08-16 WO PCT/US2002/026023 patent/WO2003016480A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885956A (en) * | 1992-12-14 | 1999-03-23 | Research Triangle Pharmaceuticals | Treatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligand |
Also Published As
Publication number | Publication date |
---|---|
US6815418B2 (en) | 2004-11-09 |
AU2002336355A1 (en) | 2003-03-03 |
US20020169119A1 (en) | 2002-11-14 |
WO2003016480A2 (en) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003016480A3 (en) | Tgf-$g(a) polypeptides, functional fragments and methods of use therefor | |
WO2003031462A3 (en) | Nogo receptor-mediated blockade of axonal growth | |
WO2004012759A3 (en) | Use of erythropoietin | |
WO2001001748A3 (en) | Peptide compounds that bind her2 | |
HK1076113A1 (en) | Specific binding agents of human angiopoietin-2 | |
EP1764370A3 (en) | Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 | |
WO2001083729A3 (en) | Vectors for ocular transduction and use thereof for genetic therapy | |
WO2003032994A3 (en) | Novel tri-substituted pyrimidines, method for production and use thereof as medicament | |
WO1998049300A3 (en) | Truncated vegf-related proteins | |
EP2301563A3 (en) | HSP20 peptides | |
WO2002078614A3 (en) | Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof | |
WO2007060213A3 (en) | Erythropoietin polypeptides and uses thereof | |
WO2002097030A3 (en) | Peptides derived from neural thread proteins and their medical use | |
WO2003014151A3 (en) | Human secreted proteins, their encoding polynucleotides, and uses thereof | |
WO2004031367A3 (en) | Uses of human zven proteins and polynucleotides | |
WO2003040296A3 (en) | Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis | |
WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
WO2003031572A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2001012127A3 (en) | TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR | |
WO2003046180A3 (en) | Human cdnas and proteins and uses thereof | |
WO2004083381A3 (en) | Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants | |
WO2003039484A3 (en) | Novel compositions and methods for cancer | |
EP2075346A3 (en) | Gene products differentially expressed in cancerous breast cells and their methods of use | |
UA84831C2 (en) | Coagulation factor vii derivatives | |
WO2002058724A8 (en) | Use of lp82 to treat body weight disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP Kind code of ref document: A2 Designated state(s): AU CA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |